Heidi L. Weiss

University of Kentucky

*This is an algorithmically generated author record based on publicly available information.

See Latest Publications

See Most Cited Publications

ORCID Profile

Google Scholar

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Research Subjects

Research Interests

Heidi L. Weiss has a total of 47 co-authors. Here are the top co-authors by number of shared publications:

Piotr Rychahou
Markey Cancer Center, University of Kentucky, Lexington, KY, USA; Department of Surgery, University of Kentucky, Lexington, KY, USA
14 shared publications
Bernard Mark Evers
University of Kentucky
13 shared publications
Dana L. Napier
Markey Cancer Center and Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, USA
13 shared publications
Dennis A. Cheek
University of Kentucky 5 Department of Radiation Medicine Lexington, Kentucky
13 shared publications
Ellen M. Reusch
Markey Cancer Center 1 Lexington, Kentucky
13 shared publications
Hunter Nathaniel Barrett Moseley
Markey Cancer Center, University of Kentucky, Lexington, KY 40506, USA
13 shared publications

Latest Publications

Sort by

Open Access
Website
Google Scholar
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Multicenter Phase I Study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388)
by Aman Chauhan, Heidi L. Weiss, Charles Kunos, Rani Jayswal, Bhavana Konda, Heloisa P. Soares, Daneng Li, Thorvardur R. Halfdanarson, Mary F. Mulcahy, Heather A. Jacene, et al.
Website
Google Scholar
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S1 from Multicenter Phase I Study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388)
by Aman Chauhan, Heidi L. Weiss, Charles Kunos, Rani Jayswal, Bhavana Konda, Heloisa P. Soares, Daneng Li, Thorvardur R. Halfdanarson, Mary F. Mulcahy, Heather A. Jacene, et al.
Open Access
Website
Google Scholar
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Multicenter Phase I Study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388)
by Aman Chauhan, Heidi L. Weiss, Charles Kunos, Rani Jayswal, Bhavana Konda, Heloisa P. Soares, Daneng Li, Thorvardur R. Halfdanarson, Mary F. Mulcahy, Heather A. Jacene, et al.
Website
Google Scholar
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S2 from Multicenter Phase I Study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388)
by Aman Chauhan, Heidi L. Weiss, Charles Kunos, Rani Jayswal, Bhavana Konda, Heloisa P. Soares, Daneng Li, Thorvardur R. Halfdanarson, Mary F. Mulcahy, Heather A. Jacene, et al.
Open Access
Website
Google Scholar
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Multicenter Phase I Study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388)
by Aman Chauhan, Heidi L. Weiss, Charles Kunos, Rani Jayswal, Bhavana Konda, Heloisa P. Soares, Daneng Li, Thorvardur R. Halfdanarson, Mary F. Mulcahy, Heather A. Jacene, et al.
Website
Google Scholar
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S3 from Multicenter Phase I Study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388)
by Aman Chauhan, Heidi L. Weiss, Charles Kunos, Rani Jayswal, Bhavana Konda, Heloisa P. Soares, Daneng Li, Thorvardur R. Halfdanarson, Mary F. Mulcahy, Heather A. Jacene, et al.
Open Access
Website
Google Scholar
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Multicenter Phase I Study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388)
by Aman Chauhan, Heidi L. Weiss, Charles Kunos, Rani Jayswal, Bhavana Konda, Heloisa P. Soares, Daneng Li, Thorvardur R. Halfdanarson, Mary F. Mulcahy, Heather A. Jacene, et al.
Pharmacokinetic profiles of triapine
Website
Google Scholar
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S4 from Multicenter Phase I Study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388)
by Aman Chauhan, Heidi L. Weiss, Charles Kunos, Rani Jayswal, Bhavana Konda, Heloisa P. Soares, Daneng Li, Thorvardur R. Halfdanarson, Mary F. Mulcahy, Heather A. Jacene, et al.
Pharmacokinetic profiles of triapine
Open Access
Website
Google Scholar
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from Multicenter Phase I Study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388)
by Aman Chauhan, Heidi L. Weiss, Charles Kunos, Rani Jayswal, Bhavana Konda, Heloisa P. Soares, Daneng Li, Thorvardur R. Halfdanarson, Mary F. Mulcahy, Heather A. Jacene, et al.
Survival plot stratified by AGGF1 and MEN1
Website
Google Scholar
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S5 from Multicenter Phase I Study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388)
by Aman Chauhan, Heidi L. Weiss, Charles Kunos, Rani Jayswal, Bhavana Konda, Heloisa P. Soares, Daneng Li, Thorvardur R. Halfdanarson, Mary F. Mulcahy, Heather A. Jacene, et al.
Survival plot stratified by AGGF1 and MEN1
Open Access
Website
Google Scholar
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from Multicenter Phase I Study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388)
by Aman Chauhan, Heidi L. Weiss, Charles Kunos, Rani Jayswal, Bhavana Konda, Heloisa P. Soares, Daneng Li, Thorvardur R. Halfdanarson, Mary F. Mulcahy, Heather A. Jacene, et al.
Website
Google Scholar
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S6 from Multicenter Phase I Study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388)
by Aman Chauhan, Heidi L. Weiss, Charles Kunos, Rani Jayswal, Bhavana Konda, Heloisa P. Soares, Daneng Li, Thorvardur R. Halfdanarson, Mary F. Mulcahy, Heather A. Jacene, et al.
Open Access
Website
Google Scholar
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Multicenter Phase I Study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388)
by Aman Chauhan, Heidi L. Weiss, Charles Kunos, Rani Jayswal, Bhavana Konda, Heloisa P. Soares, Daneng Li, Thorvardur R. Halfdanarson, Mary F. Mulcahy, Heather A. Jacene, et al.
Website
Google Scholar
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table S1 from Multicenter Phase I Study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388)
by Aman Chauhan, Heidi L. Weiss, Charles Kunos, Rani Jayswal, Bhavana Konda, Heloisa P. Soares, Daneng Li, Thorvardur R. Halfdanarson, Mary F. Mulcahy, Heather A. Jacene, et al.
Open Access
Website
Google Scholar
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Multicenter Phase I Study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388)
by Aman Chauhan, Heidi L. Weiss, Charles Kunos, Rani Jayswal, Bhavana Konda, Heloisa P. Soares, Daneng Li, Thorvardur R. Halfdanarson, Mary F. Mulcahy, Heather A. Jacene, et al.
Representativeness of study participants
Website
Google Scholar
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table S2 from Multicenter Phase I Study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388)
by Aman Chauhan, Heidi L. Weiss, Charles Kunos, Rani Jayswal, Bhavana Konda, Heloisa P. Soares, Daneng Li, Thorvardur R. Halfdanarson, Mary F. Mulcahy, Heather A. Jacene, et al.
Representativeness of study participants
Open Access
Website
Google Scholar
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Multicenter Phase I Study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388)
by Aman Chauhan, Heidi L. Weiss, Charles Kunos, Rani Jayswal, Bhavana Konda, Heloisa P. Soares, Daneng Li, Thorvardur R. Halfdanarson, Mary F. Mulcahy, Heather A. Jacene, et al.
Triapine geometric mean (SD) plasma pharmacokinetic parameters after PO administration
Website
Google Scholar
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table S4 from Multicenter Phase I Study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388)
by Aman Chauhan, Heidi L. Weiss, Charles Kunos, Rani Jayswal, Bhavana Konda, Heloisa P. Soares, Daneng Li, Thorvardur R. Halfdanarson, Mary F. Mulcahy, Heather A. Jacene, et al.
Triapine geometric mean (SD) plasma pharmacokinetic parameters after PO administration
Open Access
Website
Google Scholar
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from Multicenter Phase I Study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388)
by Aman Chauhan, Heidi L. Weiss, Charles Kunos, Rani Jayswal, Bhavana Konda, Heloisa P. Soares, Daneng Li, Thorvardur R. Halfdanarson, Mary F. Mulcahy, Heather A. Jacene, et al.
Normalized exposure matrix from Sigminer
Website
Google Scholar
- 15 October 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table S5 from Multicenter Phase I Study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388)
by Aman Chauhan, Heidi L. Weiss, Charles Kunos, Rani Jayswal, Bhavana Konda, Heloisa P. Soares, Daneng Li, Thorvardur R. Halfdanarson, Mary F. Mulcahy, Heather A. Jacene, et al.
Normalized exposure matrix from Sigminer

Show all